CalciMedica, Inc. Common Stock (CALC) — Cash Flow-to-Debt Ratio
CalciMedica, Inc. Common Stock (CALC) has a Cash Flow-to-Debt Ratio of -0.24x as of December 2025, meaning its operating cash flow of $-4.85 Million could theoretically repay 0% of its total liabilities ($20.23 Million) in one year. See financial agility of CalciMedica, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CalciMedica, Inc. Common Stock Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for CalciMedica, Inc. Common Stock across 8 annual periods. For the full cash flow conversion analysis, see CalciMedica, Inc. Common Stock (CALC) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for CalciMedica, Inc. Common Stock (2018–2025)
Year-by-year debt coverage analysis for CalciMedica, Inc. Common Stock. Check cash flow quality index of CalciMedica, Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.05x | $-21.18 Million | $20.23 Million | ▲ +73.3% |
| 2024 | -3.93x | $-21.15 Million | $5.38 Million | ▲ +38.5% |
| 2023 | -6.39x | $-25.73 Million | $4.03 Million | ▼ -583.6% |
| 2022 | -0.93x | $-11.76 Million | $12.58 Million | ▲ +87.9% |
| 2021 | -7.75x | $-31.50 Million | $4.07 Million | ▼ -69.4% |
| 2020 | -4.58x | $-32.06 Million | $7.01 Million | ▼ -79.6% |
| 2019 | -2.55x | $-31.21 Million | $12.25 Million | ▲ +47.7% |
| 2018 | -4.87x | $-28.22 Million | $5.79 Million | — |